| OSCC | Oral Squamous Cell Carcinoma |
| HSC-3 | Human Tongue Squamous Cell Carcinoma Cell Line (high metastatic) |
| SCC-9 | Oral Squamous Cell Carcinoma Cell Line (low metastatic) |
| HaCaT | Human Keratinocyte Cell Line |
| ADME | Absorption, Distribution, Metabolism, and Excretion |
| HPV | Human Papilloma Virus |
| EGF | Epidermal Growth Factor |
| TK | Tyrosine Kinase |
| TKIs | Tyrosine Kinase Inhibitors |
| RTKIs | Receptor Tyrosine Kinase Inhibitors |
| EGFR | Epidermal Growth Factor Receptor |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| HER2 | Human Epidermal Growth Factor Receptor 2 |
| NRTKIs | Non-Receptor Tyrosine Kinase Inhibitors |
| BCR-ABL | Breakpoint Cluster Region–Abelson Kinase |
| JAK | Janus Kinase |
| VEGF | Vascular Endothelial Growth Factor |
| bFGF | Basic Fibroblast Growth Factor |
| FGF-2 | Fibroblast Growth Factor-2 |
| NF-κB | Nuclear Factor Kappa B |
| p53 | Tumor Protein p53 |
| GnRHR | Gonadotropin-Releasing Hormone Receptor |
| mTOR | Mammalian Target of Rapamycin |
| IC50 | 50% Inhibitory Concentration |
| SAR | Structure–Activity Relationship |
| NRU | Neutral Red Uptake |
| SLS | Sodium Lauryl Sulfate |
| CO2 | Carbon Dioxide |
| SD | Standard Deviation |
| CC50 | 50% Cytotoxic Concentration |
| SI | Selectivity Index |
| MTT | 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide |
| PI | Propidium Iodide |
| RNase | Ribonuclease |
| PBS | Phosphate-Buffered Saline |
| PFA | Paraformaldehyde |
| BSA | Bovine Serum Albumin |
| CYP | Cytochrome P450 |
| BBB | Blood–Brain Barrier |
| P-gp | P-Glycoprotein |
| TPSA | Topological Polar Surface Area |
| ANOVA | Analysis of Variance |
| ATCC | American Type Culture Collection |